Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nutriband Inc. - Common Stock (NQ: NTRB )

7.120 -0.450 (-5.94%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nutriband Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
Via ACCESSWIRE
Nutriband Inc. Launches AI Tape Brand Direct-to Consumer Offerings
--News Direct-- 
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Nutriband Inc. (NASDAQ: NTRB) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
Nutriband Increases Existing Credit Line to $5 Million USD for the Development of its AVERSA(TM) Platform Towards FDA Submission
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Nutriband Inc. (NASDAQ: NTRB) Near the Top of Equities by Percentage Gain on 5/31
Via Investor Brand Network
Nutriband Earnings Perspective: Return On Capital Employed
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 million concurrent registered direct offering and private placement. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Nutriband Inc. Commences Trading on Upstream Under NTRB
Via ACCESSWIRE
Nutriband Inc. Will Be the First Company to Dual List on Upstream
Via ACCESSWIRE
Nutriband Approved for Dual Listing on Upstream
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Nutriband Receives Notice of Allowance for U.S. Patent Covering Transdermal Abuse Deterrent Technology
Via ACCESSWIRE
Nutriband to Attend 2023 BIO International Convention
Via ACCESSWIRE
Nutriband Inc. Reports Revenue Up 46% in Fiscal 2023
Via ACCESSWIRE
Nutriband Inc. to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023
Via ACCESSWIRE
Nutriband With Kindeva Drug Delivery Select Aversa(TM) Fentanyl Abuse Deterrent Formulation for Commercial Scale Manufacturing Process Development
Via ACCESSWIRE
Nutriband Secures $2 Million Line of Credit Financing Facility to be Used for Commercialization of AVERSA(TM) Abuse-Deterrent Transdermal Technology
Via ACCESSWIRE
Nutriband Inc Joins Webull Corporate Communications Service Platform
Via ACCESSWIRE
Nutriband COO Alan Smith Ph.D. Selected for FDA Center for Research on Complex Generics Stakeholder Expert Committee
Via ACCESSWIRE
Nutriband Inc. to File for Product Distribution Permit in South America with Ecuador's Health Register
Via ACCESSWIRE
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Via ACCESSWIRE
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Begins New Year by Trading on Upstream
Via Investor Brand Network
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Starts Trading on Upstream
Via Investor Brand Network
Nutriband Inc. to Officially Launch AI Tape brand in Q1 2023
Via ACCESSWIRE
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Approval to Dual List, to Commence Trading on Upstream
Via Investor Brand Network
Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)
Via ACCESSWIRE
Nutriband Inc. Reports Record Revenue Up 118% YoY in Q3
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.